Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02734498 · ClinicalTrials.gov registry record · NA
Prospective Treatment Study of Catatonia Patients
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02734498 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 2 participants.
The verdict
NCT02734498, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this treatment study is to compare the effectiveness of different electrode placements used in Electroconvulsive Therapy (ECT) in the treatment of catatonia. In this study Electroconvulsive Therapy will be compared to medications used in the treatment of catatonia. Medications will be administered by the primary team as part of standard of care. Medications are not primarily being used as a part of this research study. This treatments study, will be able to compare response rate of catatonia to right unilateral electroconvulsive treatment (RUL ECT) and Bilateral electroconvulsive treatment (BL ECT). Also having a control group of catatonia patients, which will not be treated with ECT will provide additional information on early ECT treatment of Catatonia.
Interventions
- DEVICE Electroconvulsive Treatment (ECT) Right Unilateral
- DEVICE Electroconvulsive Treatment (ECT) - Bilateral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-03-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02734498
The ClinicalTrials.gov registry entry for NCT02734498 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electroconvulsive Treatment (ECT) Right Unilateral is the first listed.
NCT02734498 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02734498 about?
NCT02734498 is a clinical study titled "Prospective Treatment Study of Catatonia Patients". The purpose of this treatment study is to compare the effectiveness of different electrode placements used in Electroconvulsive Therapy (ECT) in the treatment of catatonia. In this study Electroconvulsive Therapy will be compared to medications used in the treatment of catatonia. Medications will be...
What is the current status of trial NCT02734498?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-01. Estimated completion is 2017-03-19.
What interventions are being tested in trial NCT02734498?
The interventions under investigation include: Electroconvulsive Treatment (ECT) Right Unilateral (DEVICE), Electroconvulsive Treatment (ECT) - Bilateral (DEVICE).
Who is sponsoring clinical trial NCT02734498?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.